Milton Wainberg, M.D. is an HIV Center investigator who has worked on numerous studies (funded by NIMH, NIAAA, NIDA and CDC) examining substance abuse, risk for HIV, and adherence to medications. Dr. Wainberg has been particularly focused on designing and implementing national and international randomized controlled trials targeting diverse HIV-positive and at-risk populations who use alcohol or recreational drugs, experience sexual compulsivity, or have severe mental illness. He is currently testing the efficacy of an HIV prevention intervention developed in an international, collaborative, NIMH-funded project. Applying the community-based participatory research paradigm, the current project offers HIV prevention services to adults with severe mental illness throughout the municipal clinics of Rio de Janeiro, Brazil.

Current HIV Center Studies:

Behavioral Activation/Armodafinil to Treat Fatigue in HIV/AIDS

Brazilian HIV Prevention for the Severely Mentally Ill

HIV/STI Prevention for Adolescents with Substance Use Disorder in Treatment

<back to top>